156 results
8-K
EX-10.1
MDGL
Madrigal Pharmaceuticals, Inc.
27 Jun 24
Departure of Directors or Certain Officers
4:28pm
without such Participant’s consent or in the event of death of the Participant the Participant’s Survivors; and (iii) any such amendment shall be made … ON OPTIONS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE OR DEATH OR DISABILITY.
Except as otherwise provided in a Participant’s Option Agreement
424B3
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Prospectus supplement
4:34pm
to cirrhosis, decompensated cirrhosis, liver transplant or death, and cardiovascular risks, comorbidities and outcomes;
Optimal dosing levels for resmetirom … transplant or death, and cardiovascular risks, comorbidities and outcomes;
Optimal dosing levels for resmetirom and projections regarding potential NASH
424B5
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Prospectus supplement for primary offering
4:29pm
cirrhosis, liver transplant or death, and cardiovascular risks, comorbidities and outcomes;
Optimal dosing levels for resmetirom and projections regarding … or death, and cardiovascular risks, comorbidities and outcomes;
Optimal dosing levels for resmetirom and projections regarding potential NASH or NAFLD
S-3ASR
MDGL
Madrigal Pharmaceuticals, Inc.
7 May 24
Automatic shelf registration
4:06pm
with significant fibrosis concerning potential progression to cirrhosis, decompensated cirrhosis, liver transplant or death, and cardiovascular risks
8-K
EX-99.1
lkrgo6vc
7 May 24
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
7:06am
424B5
yss2507qyu mg
20 Mar 24
Prospectus supplement for primary offering
4:06pm
424B5
1g5b9b5iicyt
18 Mar 24
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
qlwuiogvijw
14 Mar 24
Regulation FD Disclosure
6:47pm
8-K
EX-99.2
5appmxj dkrtxyh4k83
14 Mar 24
Regulation FD Disclosure
6:47pm
8-K
EX-99.1
wgh 04xbn
28 Feb 24
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full
7:01am
8-K
EX-99.1
kq988cdci
8 Jan 24
Other Events
1:45pm
424B5
6qvcdlzavqikiz0
2 Oct 23
Prospectus supplement for primary offering
5:10pm
424B5
pxq7n4ves62
28 Sep 23
Prospectus supplement for primary offering
4:01pm
8-K
ea7 1k472x
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
xdvq5i1ei2fw4hy8f
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
S-8
EX-99.2
70s5tvnrzxyh79nlc
11 Sep 23
Registration of securities for employees
4:31pm